To my fellow BMSN longs: I'm very excited to be a
Post# of 5066
I'm very excited to be amongst this group of shareholders. I, as many of us, am waiting on FDA approval with patience and enthusiasm. The approach being taken by Thomas, not to mention Christine at sister company ENTB, is not only cutting edge and likely profitable but, also, humane; such a stark comparison to the current orthodoxy of 'cut, burn, and poison'. To silence the gene and minimize side effects from treatments, while preserving healthy cell function required for aerobic mitochondrial respiration while allowing no epigenetic expression of anaerobic respiration and fermentation prevalent in the environment inducing proliferation of cancer cells, is, quite honestly, a major step in the right direction. These two CSO's are doing this from an impassioned intrinsic motivation after losing their mother to the disease they are set out to cure. I am rooting for them, as a company and as people. Holding a few million shares and have not sold. Adding more is the plan. $BMSN all the way.